source
- MoonLake reports all endpoints met in phase 3 trial of sonelokimab for psoriatic arthritisMoonLake Immunotherapeutics said its lead nanobody sonelokimab achieved positive topline results in a phase 3 study of patients with psoriatic arthritis. At week 16, 42.1% of participants reached…
- Global Ebola preparedness fixated on one strain, leaving other species vulnerableIn an opinion piece, infectious-diseases physician Krutika Kuppalli and virologist Placide Mbala argue that the term "Ebola" masks several distinct virus species, each with different diagnostic and…